Speculation that Hospira (HSP -2.3%) shares have become so cheap in the face of scrutiny for...

|By:, SA News Editor

Speculation that Hospira (HSP -2.3%) shares have become so cheap in the face of scrutiny for flaws in its manufacturing practices that the company may become a takeover target isn't helping the stock today. A potential FDA consent decree over alleged safety violations at one plant would slow production and perhaps even lead to a complete shutdown of the facility.